Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - Cardiff Oncology, Inc. | a15-1864_1ex32d2.htm |
EX-10.7 - EX-10.7 - Cardiff Oncology, Inc. | a15-1864_1ex10d7.htm |
EX-23.1 - EX-23.1 - Cardiff Oncology, Inc. | a15-1864_1ex23d1.htm |
EX-31.1 - EX-31.1 - Cardiff Oncology, Inc. | a15-1864_1ex31d1.htm |
EX-31.2 - EX-31.2 - Cardiff Oncology, Inc. | a15-1864_1ex31d2.htm |
EX-10.8 - EX-10.8 - Cardiff Oncology, Inc. | a15-1864_1ex10d8.htm |
EX-10.6 - EX-10.6 - Cardiff Oncology, Inc. | a15-1864_1ex10d6.htm |
EX-32.1 - EX-32.1 - Cardiff Oncology, Inc. | a15-1864_1ex32d1.htm |
EXCEL - IDEA: XBRL DOCUMENT - Cardiff Oncology, Inc. | Financial_Report.xls |
10-K - 10-K - Cardiff Oncology, Inc. | a15-1864_110k.htm |
Exhibit 21
List of Subsidiaries
Xenomics, Inc., a California corporation
Etherogen, Inc., a Delaware corporation